<--- Back to Details
First PageDocument Content
American Thoracic Society / American Association for Respiratory Care / Pulmonology / Tuberculosis treatment / Chronic obstructive pulmonary disease / Cystic fibrosis / Physical therapy / Pulmonary Hypertension Association / Respiratory disease / Medicine / Health / Respiratory therapy
Date: 2014-06-03 13:29:26
American Thoracic Society
American Association for Respiratory Care
Pulmonology
Tuberculosis treatment
Chronic obstructive pulmonary disease
Cystic fibrosis
Physical therapy
Pulmonary Hypertension Association
Respiratory disease
Medicine
Health
Respiratory therapy

Add to Reading List

Source URL: patients.thoracic.org

Download Document from Source Website

File Size: 2,70 MB

Share Document on Facebook

Similar Documents

For immediate release March 21, 2017 Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- Infecte

DocID: 1vkmw - View Document

PRESS RELEASE Adequate treatment essential to stop TB across Europe – new ECDC/WHO report Stockholm/Copenhagen, 19 MarchOverpatients are estimated to fall sick with tuberculosis (TB) every day across Euro

DocID: 1saSR - View Document

JOINT PRESS RELEASE New ECDC-WHO report: tuberculosis on the retreat in Europe. Concerns about drugresistant TB and treatment failure. Stockholm/Copenhagen, 19 March 2012

DocID: 1rHnT - View Document

Tuberculosis / Medicine / Clinical medicine / Health / Tuberculosis management / Tuberculosis diagnosis / DOTS / World Tuberculosis Day / TB Alert / Tuberculosis in India

15 | P a g e Multiple healthcare Seeking behaviors of new Smear positive pulmonary tuberculosis patients attending a diagnosis and treatment center of Bafoussam- Cameroon ABSTRACT FABRICE NEMBOT DJOUMA , ARMELLE VIVIAN

DocID: 1qzgC - View Document

Tuberculosis / Clinical medicine / Health / Medicine / Multi-drug-resistant tuberculosis / Bedaquiline / Tuberculosis management / Latent tuberculosis

Embargoed: 12 May – 1130 hrs CEST WORLD HEALTH ORGANIZATION RECOMMENDS SHORTENED NINE-MONTH TREATMENT REGIMEN FOR MDR-TB PATIENTS

DocID: 1q2l5 - View Document